Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA422443
Max Phase: Preclinical
Molecular Formula: C24H20O3
Molecular Weight: 356.42
Molecule Type: Small molecule
Associated Items:
ID: ALA422443
Max Phase: Preclinical
Molecular Formula: C24H20O3
Molecular Weight: 356.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1c2c(O)cccc2C(=CCCCc2ccccc2)c2cccc(O)c21
Standard InChI: InChI=1S/C24H20O3/c25-20-14-6-12-18-17(11-5-4-10-16-8-2-1-3-9-16)19-13-7-15-21(26)23(19)24(27)22(18)20/h1-3,6-9,11-15,25-26H,4-5,10H2
Standard InChI Key: PUVHMMKQQHFVRS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 356.42 | Molecular Weight (Monoisotopic): 356.1412 | AlogP: 5.10 | #Rotatable Bonds: 4 |
Polar Surface Area: 57.53 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.29 | CX Basic pKa: | CX LogP: 7.18 | CX LogD: 7.12 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.50 | Np Likeness Score: 0.66 |
1. Müller K, Gürster D, Piwek S, Wiegrebe W.. (1993) Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase., 36 (25): [PMID:8258834] [10.1021/jm00077a015] |
Source(1):